Clincosm LogoSign in Get a demo

secondary hyperparathyroidism

Showing 1 - 25 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

d to Reveal Heterogeneity of Secondary Hyperparathyroidism

Not yet recruiting
  • Secondary Hyperparathyroidism
  • Single-cell sequencing
  • (no location specified)
Nov 12, 2023

Efficacy and Safety of Pacitol Inj.

Recruiting
  • Chronic Kidney Disease 5D
  • Secondary Hyperparathyroidism
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      DongGuk university Ilsan hospital
    Nov 6, 2023

    Precision Medicine Approaches to Renal Osteodystrophy

    Recruiting
    • Renal Osteodystrophy
    • +4 more
      • New York, New York
        Columbia University Irving Medical Center
      May 28, 2023

      Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)

      Not yet recruiting
      • Secondary Hyperparathyroidism
      • End Stage Kidney Disease
      • (no location specified)
      Apr 18, 2023

      Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)

      Not yet recruiting
      • Secondary Hyperparathyroidism
      • (no location specified)
      Apr 17, 2023

      Secondary Hyperparathyroidism Trial (SHR6508, Cinacalcet)

      Not yet recruiting
      • Secondary Hyperparathyroidism
      • (no location specified)
      Dec 21, 2022

      Secondary Hyperparathyroidism Trial in Worldwide (Etelcalcetide)

      Recruiting
      • Secondary Hyperparathyroidism
      • Gent, Belgium
      • +19 more
      Dec 8, 2022

      Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis Trial in Saint Petersburg

      Completed
      • Secondary Hyperparathyroidism
      • +4 more
      • Saint Petersburg, Russian Federation
        Saint-Petersburg State University Hospital
      Nov 7, 2022

      Parathyroidectomy on Cardiovascular Calcification in

      Active, not recruiting
      • Secondary Hyperparathyroidism
      • +3 more
        • Saint Petersburg, Russian Federation
          Saint-Petersburg State University, Clinic of advanced medical te
        Nov 2, 2022

        3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

        Not yet recruiting
        • Parathyroid Gland Disease
        • Secondary Hyperparathyroidism
          • (no location specified)
          Sep 15, 2022

          Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency Trial (CTAP101, Placebo)

          Not yet recruiting
          • Chronic Kidney Disease stage3
          • +3 more
          • (no location specified)
          Sep 13, 2022

          Secondary Hyperparathyroidism Trial in Worldwide (KHK7580, Cinacalcet Hydrochloride)

          Completed
          • Secondary Hyperparathyroidism
          • Changsha, China
          • +33 more
          Apr 21, 2022

          Secondary Hyperparathyroidism Trial in Baltimore (Teriparatide)

          Completed
          Has Results
          • Secondary Hyperparathyroidism
          • Baltimore, Maryland
            University of Maryland School of Medicine Division of Endocrinol
          Mar 30, 2022

          Secondary Hyperparathyroidism Trial (Paricalcitol, Placebo)

          Not yet recruiting
          • Secondary Hyperparathyroidism
          • (no location specified)
          Jan 27, 2022

          Secondary Hyperparathyroidism Trial (SHR6508;Placebo)

          Not yet recruiting
          • Secondary Hyperparathyroidism
          • SHR6508；Placebo
          • (no location specified)
          Jan 20, 2022

          Kidney Failure, Secondary Hyperparathyroidism, Vascular Diseases Trial in Hong Kong (Cinacalcet, Surgical total

          Completed
          • Kidney Failure
          • +2 more
          • Cinacalcet
          • Surgical total parathyroidectomy with forearm autografting
          • Hong Kong, Hong Kong
            Queen Mary Hospital and Tung Wah Hospital
          Oct 4, 2021

          Compromised Bone Quality and Mechanics in Chronic Kidney Disease

          Completed
          • Chronic Kidney Disease
          • +4 more
          • Kidney disease
          • New York, New York
            Columbia/CUMC
          Jul 11, 2021

          Secondary Hyperparathyroidism, Chronic Kidney Disease Trial in Worldwide (Etelcalcetide, Cinacalcet)

          Completed
          Has Results
          • Secondary Hyperparathyroidism
          • Chronic Kidney Disease
          • Beijing, Beijing, China
          • +89 more
          Apr 5, 2021

          Secondary Hyperparathyroidism, Hypercalcemia Trial in Bronx (Cinacalcet HCl)

          Terminated
          • Secondary Hyperparathyroidism
          • Hypercalcemia
          • Cinacalcet HCl
          • Bronx, New York
            Montefiore Medical Center
          Apr 22, 2021

          Successful Surgery in Secondary Hyperparathyroidism

          Completed
          • Secondary Hyperparathyroidism
          • Intraoperative Paratohormone
          • Mexico city, Mexico
            Hospital General Ajusco Medio
          Jul 20, 2020

          Chronic Kidney Disease, Hyperparathyroidism, Hyperparathyroidism, Secondary Trial in Worldwide (cinacalcet capsule, , Standard

          Terminated
          Has Results
          • Chronic Kidney Disease
          • +4 more
          • cinacalcet capsule
          • +2 more
          • Birmingham, Alabama
          • +50 more
          Jun 12, 2020

          The Longitudinal PTH-Study

          Completed
          • CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
          • +2 more
          • One armed study, blood from each patient is analysed by four assays ( two 3rd generation and two 2nd generation assays)
          • Vienna, Austria
            Department of Internal Medicine III, Division of Nephrology and
          Jun 23, 2020

          Secondary Hyperparathyroidism, Chronic Kidney Disease Requiring Chronic Dialysis, Left Ventricular Hypertrophy Trial in Vienna

          Completed
          • Secondary Hyperparathyroidism
          • +2 more
          • cardiac MRI
          • +4 more
          • Vienna, Austria
          • +1 more
          Jun 4, 2020

          Secondary Hyperparathyroidism Trial in Tokyo (SK-1403, Placebo)

          Completed
          • Secondary Hyperparathyroidism
          • Tokyo, Japan
            Investigational site (there may be other sites in this country)
          Mar 6, 2020

          Secondary Hyperparathyroidism Trial in Tokyo (SK-1403)

          Completed
          • Secondary Hyperparathyroidism
          • Tokyo, Japan
            Investigational site (there may be other sites in this country)
          Mar 6, 2020